Trial Information
Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
Inclusion Criteria:
- Neuroblastoma patients with complete follow-up and sufficient samples for study
Exclusion Criteria:
- Neuroblastoma patients without complete follow-up or sufficient samples for study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Wen-Ming Hsu, M.D, Ph.D
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Taiwan Univesity Hospital
Authority:
Taiwan: Department of Health
Study ID:
200910002R
NCT ID:
NCT01638572
Start Date:
January 2010
Completion Date:
December 2011
Related Keywords:
- Neuroblastoma
- Neuroblastoma
- B4GALNT3
- Prognosis
- Neuroblastoma